Bioprinting for the treatment of diabetes

Bioprinting is being utilized for the 3D printing of human adipose derived stem cells and islets which could have the potential to treat type 1 diabetic patients. Oslo University Hospital (Oslo, Norway) has developed an islet isolation and manufacturing facility, to be able to transplant human islets to try to meet the demand for islet transplants for diabetes type 1 patients. Hanne Scholz, Manager of islet transplantation unit and director of Oslo Regenerative Medicine Cluster (Oslo University Hospital), has turned to 3D bioprinting and collaborated with Norwegian Biotech start-up CELLHEAL and Chalmers University of Technology (Gotenburg, Sweden). 3D bioprinting may...